A Phase 2 trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus is being conducted at four U.S. sites, including at Baylor College of Medicine.
Researchers at the Human Genome Sequencing Center have established a registry to collect genetic and other clinical information from patients with Xia-Gibbs Syndrome.
A National Institutes of Health grant is a commitment to continue the impactful work being done through the Texas Medical Center Digestive Diseases Center.
The mechanisms that control triglycerides are now the target for a new clinical trial at Baylor College of Medicine looking to lower high triglyceride levels in people diagnosed with cardiovascular disease.
Researchers from Baylor College of Medicine and the CDC evaluated whether a mobile app could improve diagnostic and test ordering decisions of physicians.
An international group of researchers, including researchers from Baylor College of Medicine, seek to sequence every known species that calls planet Earth home.
Baylor researchers have contributed significant work to The Cancer Genome Atlas, which in turn has produced game changers for translational research and clinical trials.
The recent development of a large versatile library of fruit flies can be used to perform efficient and elegant in vivo gene-specific manipulations using the new protocol and gene-specific integration vector CRISPR-Mediated Integrated Cassette.
Researchers at Baylor College of Medicine have received $3,568,639 from the Cancer Prevention and Research Institute of Texas for three new grants focused on tobacco control, cancer screening and novel treatments for cancer in children and adults
